Advertisement
Friday, Sep 24, 2021
Outlook.com
Outlook.com

WHO Advises Against Use Of Remdesivir For Covid-19 Treatment

WHO-led trial concludes that drug has little or no effect on Covid-19 symptoms.

WHO Advises Against Use Of Remdesivir For Covid-19 Treatment
| AP Photo/Anja Niedringhaus
WHO Advises Against Use Of Remdesivir For Covid-19 Treatment
outlookindia.com
2020-11-20T22:01:58+05:30

The World Health Organisation (WHO) on Friday advised against the use of Gilead’s Remdesivir saying that it is not to be used for the treatment of Covid-19 patients no matter how ill they are. A WHO panel said that there is no evidence to suggest that the drug improves survival or reduces the need for ventilation.

"The ... panel found a lack of evidence that remdesivir improved outcomes that matter to patients such as reduced mortality, need for mechanical ventilation, time to clinical improvement, and others," the guideline said.

After reviewing the evidence WHO concluded that the drug leads to “no important effect on mortality, need for mechanical ventilation, time to clinical improvement, and other patient-important outcomes.”

WHO’s recommendation was part of a living guideline on clinical care for COVID-19. It was developed by an international guideline development group, which includes 28 clinical care experts, 4 patient-partners and one ethicist.

The antiviral drug grabbed worldwide attention as a potentially effective treatment for Covid-19 in the summer after early trials showed some promise.

The medication was also used to treat US President Donald Trump’s coronavirus infection. However, a WHO-led trial known as the Solidarity Trial showed last month that it had little or no effect on Covid-19 symptoms.

Work on WHO’s trial began on October 15 and the data reviewed by the panel included results from this trial, as well as 3 other randomized controlled trials. In all, data from over 7000 patients across the 4 trials were considered.

Advertisement

Outlook Newsletters

Advertisement

Read More from Outlook

The Password Is Cheat: Tech-Savvy Scamsters Take Control Of Online Entrance Exams

The Password Is Cheat: Tech-Savvy Scamsters Take Control Of Online Entrance Exams

Prestigious tests like JEE and NEET have been breached. A few lakh of rupees can get you an engineering or a medical seat.

Can The Govt Convince Moody’s To Upgrade India’s Sovereign Ratings?

Can The Govt Convince Moody’s To Upgrade India’s Sovereign Ratings?

While cutting India’s rating, Moody’s had cited policy challenges in addressing a prolonged economic slowdown and its deteriorating fiscal position.

Broken Foot: An Artist's Comment On India's Caste System

Broken Foot: An Artist's Comment On India's Caste System

Mumbai-based artist, Prabhakar Kamble spoke to Outlook about his work – Broken Foot which appears on the cover of our latest edition. On the stands today.

Hathras: A Poet's Comment On A Post-Truth World

Hathras: A Poet's Comment On A Post-Truth World

It disturbing but it is important to remember that violence repeats itself in the same ways. Meena Kandasamy's poem is a poem that is invested in the social.

Advertisement